Bright Minds Biosciences (DRUG) - 2024 Q2 - Quarterly Report

Bright Minds Biosciences Inc. Condensed Interim Consolidated Financial Statements For the six months ended March 31, 2024 and 2023 (Expressed in Canadian Dollars) Bright Minds Biosciences Inc. Condensed Interim Consolidated Statements of Financial Position (Expressed in Canadian dollars) | | | March 31, | September 30, | | --- | --- | --- | --- | | | | 2024 | 2023 | | As at | Notes | (unaudited) | (audited) | | | | $ | $ | | ASSETS | | | | | Current Assets | | | | | Cash and cash equivalents | 8 | 5,932,436 ...